Sunesis Pharmaceuticals to Present at Lehman Brothers Ninth Annual Global Healthcare Conference
March 08 2006 - 8:30AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., March 8 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that
Daniel N. Swisher, Jr., President and Chief Executive Officer, will
present a company update at the Lehman Brothers Ninth Annual Global
Healthcare Conference in South Beach, FL on March 10, 2006 at 11:15
a.m. local time. Interested parties may access the webcast of the
presentation by visiting the Sunesis website at
http://ir.sunesis.com/ . A replay of the webcast will be archived
on the "Calendar of Events" page in the Investors and Media section
of the Sunesis website for two weeks until March 24, 2006. About
Sunesis Pharmaceuticals Sunesis is a clinical-stage
biopharmaceutical company focused on the discovery, development and
commercialization of novel small molecule therapeutics for oncology
and other serious diseases. Sunesis has built a broad product
candidate portfolio through internal discovery and in-licensing of
novel cancer therapeutics. Sunesis is advancing its product
candidates through in-house research and development efforts and
strategic collaborations with leading pharmaceutical and
biopharmaceutical companies. For further information on Sunesis
Pharmaceuticals, please visit http://www.sunesis.com/ .
Forward-Looking Statements This press release may contain
forward-looking statements that involve substantial risks and
uncertainties. Sunesis may not actually achieve the plans,
intentions or expectations contained in such forward-looking
statements. Actual results or events could differ materially from
the plans, intentions and expectations contained in such
forward-looking statements. Sunesis does not assume any obligation
to update any such forward-looking statements. DATASOURCE: Sunesis
Pharmaceuticals, Inc. CONTACT: investors, Eric Bjerkholt, CFO of
Sunesis Pharmaceuticals, Inc., +1-650-266-3717; or media, Karen L.
Bergman, +1-650-575-1509, or Michelle Corral, +1-415-794-8662, both
of BCC Partners, for Sunesis Pharmaceuticals, Inc. Web site:
http://ir.sunesis.com/ Web site: http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024